2021•Zenodo (CERN European Organization for Nuclear Research)Open access

Individual Efficacy and Community Impact of Ivermectin, Diethylcarbamazine, and Albendazole Mass Drug Administration for Lymphatic Filariasis Control in Fiji: A Cluster Randomized Trial

Myra Hardy, Josaia Samuela, Mike Kama, Meciusela Tuicakau, Romani, Lucia, Margot J. Whitfeld, Christopher L. King, Gary J. Weil, Anneke C Grobler, Leanne J. Robinson, John Martin Kaldor, Andrew C. Steer

Open full text 0 citations

Abstract

This is the accepted manuscript version of the work published in its final form as Hardy, Myra; Samuela, Josaia; Kama, Mike; Tuicakau, Meciusela; Romani, Lucia; Whitfeld, Margot J; King, Christopher L; Weil, Gary J; Grobler, Anneke C; Robinson, Leanne J; Kaldor, John M; Steer, Andrew C. Clinical Infectious Diseases; Volume: 73; Issue: 6. https://doi.org/10.1093/cid/ciab202. Deposited by shareyourpaper.org and openaccessbutton.org. We've taken reasonable steps to ensure this content doesn't violate copyright. However, if you think it does you can request a takedown by emailing help@openaccessbutton.org.

About this research paper

What this paper is about

This is the accepted manuscript version of the work published in its final form as Hardy, Myra; Samuela, Josaia; Kama, Mike; Tuicakau, Meciusela; Romani, Lucia; Whitfeld, Margot J; King, Christopher L; Weil, Gary J; Grobler, Anneke C; Robinson, Leanne J; Kaldor, John M; Steer, Andrew C. Clinical Infectious Diseases; Volume: 73; Issue: 6. https://doi.org/10.1093/cid/ciab202. Deposited by shareyourpaper.org and openaccessbutton.org. We've taken reasonable steps to ensure this content doesn't violate copyright. However, if you think it does you can request a takedown by emailing help@openaccessbutton.org.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

This is the accepted manuscript version of the work published in its final form as Hardy, Myra; Samuela, Josaia; Kama, Mike; Tuicakau, Meciusela; Romani, Lucia; Whitfeld, Margot J; King, Christopher L; Weil, Gary J; Grobler, Anneke C; Robinson, Leanne J; Kaldor, John M; Steer, Andrew C. Clinical Infectious Diseases; Volume: 73; Issue: 6. https://doi.org/10.1093/cid/ciab202. Deposited by shareyourpaper.org and openaccessbutton.org. We've taken reasonable steps to ensure this content doesn't violate copyright. However, if you think it does you can request a takedown by emailing help@openaccessbutton.org.

Key concepts: Lymphatic filariasis, Mass drug administration, Diethylcarbamazine, Ivermectin, Albendazole, Medicine, Anthelmintic, Cluster randomised controlled trial

Related papers

Back to paper searchBrowse research topicsOriginal source
Individual Efficacy and Community Impact of Ivermectin, Diethylcarbamazine, and Albendazole Mass Drug Administration for Lymphatic Filariasis Control in Fiji: A Cluster Randomized Trial — Research Paper | ScholarLens